MA41124A - Compositions en suspension à libération prolongée à rétention gastrique - Google Patents
Compositions en suspension à libération prolongée à rétention gastriqueInfo
- Publication number
- MA41124A MA41124A MA041124A MA41124A MA41124A MA 41124 A MA41124 A MA 41124A MA 041124 A MA041124 A MA 041124A MA 41124 A MA41124 A MA 41124A MA 41124 A MA41124 A MA 41124A
- Authority
- MA
- Morocco
- Prior art keywords
- extended
- gastric retention
- suspension compositions
- release suspension
- release
- Prior art date
Links
- 229940102215 extended release suspension Drugs 0.000 title 1
- 230000002496 gastric effect Effects 0.000 title 1
- 230000014759 maintenance of location Effects 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
- A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
- A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
- A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5089—Processes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN3553DE2014 | 2014-12-05 |
Publications (1)
Publication Number | Publication Date |
---|---|
MA41124A true MA41124A (fr) | 2017-10-10 |
Family
ID=56091086
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA041124A MA41124A (fr) | 2014-12-05 | 2015-04-30 | Compositions en suspension à libération prolongée à rétention gastrique |
Country Status (10)
Country | Link |
---|---|
US (1) | US20180008539A1 (fr) |
EP (1) | EP3226839A4 (fr) |
JP (1) | JP2017536404A (fr) |
AU (1) | AU2015356781A1 (fr) |
BR (1) | BR112017011922A2 (fr) |
CA (1) | CA2969820A1 (fr) |
MA (1) | MA41124A (fr) |
MX (1) | MX2017007299A (fr) |
RU (1) | RU2017123366A (fr) |
WO (1) | WO2016087952A1 (fr) |
Families Citing this family (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2794171C (fr) | 2010-03-24 | 2018-07-03 | Jazz Pharmaceuticals, Inc. | Formes galeniques a liberation controlee pour des substances medicamenteuses hydrosolubles et hygroscopiques a dose elevee |
US10398662B1 (en) | 2015-02-18 | 2019-09-03 | Jazz Pharma Ireland Limited | GHB formulation and method for its manufacture |
US11602512B1 (en) | 2016-07-22 | 2023-03-14 | Flamel Ireland Limited | Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics |
US11602513B1 (en) | 2016-07-22 | 2023-03-14 | Flamel Ireland Limited | Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics |
US11504347B1 (en) | 2016-07-22 | 2022-11-22 | Flamel Ireland Limited | Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics |
UY37341A (es) | 2016-07-22 | 2017-11-30 | Flamel Ireland Ltd | Formulaciones de gamma-hidroxibutirato de liberación modificada con farmacocinética mejorada |
US20190282500A1 (en) * | 2016-09-09 | 2019-09-19 | Cutispharma, Inc. | Suspensions and diluents for metronidazole and baclofen |
US20180263936A1 (en) | 2017-03-17 | 2018-09-20 | Jazz Pharmaceuticals Ireland Limited | Gamma-hydroxybutyrate compositions and their use for the treatment of disorders |
US20210015744A1 (en) * | 2017-12-18 | 2021-01-21 | Tris Pharma, Inc. | Pharmaceutical compositions comprising a floating interpenetrating polymer network forming system |
US11337919B2 (en) | 2017-12-18 | 2022-05-24 | Tris Pharma, Inc. | Modified release drug powder composition comprising gastro-retentive RAFT forming systems having trigger pulse drug release |
US11337920B2 (en) | 2017-12-18 | 2022-05-24 | Tris Pharma, Inc. | Pharmaceutical composition comprising GHB gastro-retentive raft forming systems having trigger pulse drug release |
EP3737353A1 (fr) | 2017-12-18 | 2020-11-18 | Tris Pharma, Inc. | Compositions pharmaceutiques de ghb comprenant un système de formation de réseau polymère interpénétrant flottant |
CA3107139C (fr) | 2018-09-21 | 2023-01-03 | Kashiv Biosciences, Llc | Compositions a liberation prolongee comprenant du trihexyphenidyle |
CN113395960A (zh) | 2018-11-19 | 2021-09-14 | 爵士制药爱尔兰有限公司 | 抗酒精药物制剂 |
JP2022515067A (ja) * | 2018-12-18 | 2022-02-17 | ニュートリション アンド バイオサイエンシズ ユーエスエー 1,リミティド ライアビリティ カンパニー | メチルセルロースを含む徐放性組成物 |
JP2022515069A (ja) * | 2018-12-18 | 2022-02-17 | ニュートリション アンド バイオサイエンシズ ユーエスエー 1,リミティド ライアビリティ カンパニー | エチルセルロースを含む徐放性組成物 |
US11400065B2 (en) | 2019-03-01 | 2022-08-02 | Flamel Ireland Limited | Gamma-hydroxybutyrate compositions having improved pharmacokinetics in the fed state |
US11389398B2 (en) | 2019-05-14 | 2022-07-19 | Clexio Biosciences Ltd. | Gastroretentive treatment of nocturnal symptoms and morning akinesia in subjects with parkinson's disease |
US10792262B1 (en) * | 2019-07-29 | 2020-10-06 | Saol International Limited | Stabilized formulations of 4-amino-3-substituted butanoic acid derivatives |
US11654124B2 (en) | 2019-07-29 | 2023-05-23 | Amneal Pharmaceuticals Llc | Stabilized formulations of 4-amino-3-substituted butanoic acid derivatives |
CN112516159B (zh) * | 2020-12-03 | 2022-06-17 | 爱希(北京)国际咨询有限公司 | 一种含有硝酸盐的组合物、胃漂浮剂及制备方法和应用 |
US11154505B1 (en) | 2021-02-03 | 2021-10-26 | Kashiv Specialty Pharmaceuticals, Llc | Extended release compositions comprising trihexyphenidyl |
WO2022195476A1 (fr) | 2021-03-15 | 2022-09-22 | Clexio Biosciences Ltd. | Dispositifs de rétention gastrique pour l'évaluation d'états intragastriques |
CN112933055B (zh) * | 2021-03-23 | 2023-01-13 | 安徽九华华源药业有限公司 | 帕利哌酮胃滞留片及其制备方法 |
US11779557B1 (en) | 2022-02-07 | 2023-10-10 | Flamel Ireland Limited | Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics |
US11583510B1 (en) | 2022-02-07 | 2023-02-21 | Flamel Ireland Limited | Methods of administering gamma hydroxybutyrate formulations after a high-fat meal |
WO2024030936A1 (fr) * | 2022-08-02 | 2024-02-08 | Nutrition & Biosciences Usa 1, Llc | Composition à base d'alginate à libération modifiée |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5273760A (en) * | 1991-12-24 | 1993-12-28 | Euroceltigue, S.A. | Stabilized controlled release substrate having a coating derived from an aqueous dispersion of hydrophobic polymer |
ATE306250T1 (de) * | 1998-12-23 | 2005-10-15 | Alza Corp | Dosierungsformen, die poröse partikel enthalten |
JP2004002320A (ja) * | 2002-03-04 | 2004-01-08 | Medorekkusu:Kk | 生体内で相転移する液状マトリックスおよび液状経口製剤 |
IL164222A0 (en) * | 2002-04-09 | 2005-12-18 | Flamel Tech Sa | Oral pharmaceutical formulation in the form of aqueous suspension for modified release of active principle(s) |
US20050207983A1 (en) * | 2004-03-05 | 2005-09-22 | Pulmatrix, Inc. | Formulations decreasing particle exhalation |
CN101160126A (zh) * | 2005-04-20 | 2008-04-09 | 默克公司 | 血管紧张肽ⅱ受体拮抗剂 |
CA2678367C (fr) * | 2007-03-02 | 2014-07-08 | Farnam Companies, Inc. | Compositions a liberation prolongee utilisant des matieres cireuses |
WO2008122993A1 (fr) * | 2007-04-09 | 2008-10-16 | Panacea Biotec Limited | Formulation de microparticules enrobées à libération contrôlée |
JP2010523708A (ja) * | 2007-04-11 | 2010-07-15 | バイオマリン ファーマシューティカル インコーポレイテッド | テトラヒドロビオプテリンを投与する方法、関連する組成物および測定方法 |
WO2010011466A2 (fr) * | 2008-06-27 | 2010-01-28 | Otonomy, Inc. | Compositions de modulation du snc à libération contrôlée et procédés de traitement des troubles otiques |
WO2011107855A2 (fr) * | 2010-03-04 | 2011-09-09 | Torrent Pharmaceuticals Limited | Forme dosifiée sous forme de suspension liquide à libération prolongée pour une administration par voie orale |
MX2016014320A (es) * | 2014-05-01 | 2017-05-23 | Sun Pharmaceutical Ind Ltd | Composiciones de suspension de liberacion prolongada. |
-
2015
- 2015-04-30 MA MA041124A patent/MA41124A/fr unknown
- 2015-05-01 BR BR112017011922A patent/BR112017011922A2/pt not_active Application Discontinuation
- 2015-05-01 CA CA2969820A patent/CA2969820A1/fr not_active Abandoned
- 2015-05-01 US US15/533,285 patent/US20180008539A1/en not_active Abandoned
- 2015-05-01 JP JP2017529675A patent/JP2017536404A/ja active Pending
- 2015-05-01 RU RU2017123366A patent/RU2017123366A/ru not_active Application Discontinuation
- 2015-05-01 EP EP15866100.9A patent/EP3226839A4/fr not_active Withdrawn
- 2015-05-01 WO PCT/IB2015/053208 patent/WO2016087952A1/fr active Application Filing
- 2015-05-01 AU AU2015356781A patent/AU2015356781A1/en not_active Abandoned
- 2015-05-01 MX MX2017007299A patent/MX2017007299A/es unknown
Also Published As
Publication number | Publication date |
---|---|
AU2015356781A1 (en) | 2017-06-29 |
EP3226839A1 (fr) | 2017-10-11 |
BR112017011922A2 (pt) | 2018-01-16 |
WO2016087952A1 (fr) | 2016-06-09 |
RU2017123366A (ru) | 2019-01-10 |
US20180008539A1 (en) | 2018-01-11 |
JP2017536404A (ja) | 2017-12-07 |
RU2017123366A3 (fr) | 2019-01-10 |
CA2969820A1 (fr) | 2016-06-09 |
MX2017007299A (es) | 2017-08-25 |
EP3226839A4 (fr) | 2018-07-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MA41124A (fr) | Compositions en suspension à libération prolongée à rétention gastrique | |
DK3731771T3 (da) | V462033dk00 | |
MA44702A (fr) | Compositions de suspension à libération prolongée | |
DE202018003363U8 (de) | Handgelenkssphygmomanometer | |
CL2018000524S1 (es) | Golilla | |
DK3351526T3 (da) | Diisopentylterephthalat | |
DK3568655T3 (da) | Rekuperator | |
DK3571580T5 (da) | Load-logical-and-shift-guarded-instruktion | |
KR20180084876A (ko) | 내플라즈마성 부재 | |
MA45305A (fr) | Suspension améliorée | |
DK3612237T3 (da) | Genterapi | |
DK3438103T3 (da) | Griseofulvinforbindelse | |
DK3568506T3 (da) | Offeranode | |
DK3576686T3 (da) | Brokbind | |
DK3352735T3 (da) | Olanzapinformuleringer med langvarig frigivelse | |
DK3676276T3 (da) | Spirothietannukleosider | |
DK3576718T3 (da) | Pastil | |
FI11704U1 (fi) | Liittopuujärjestely | |
DK3510051T3 (da) | Carboxylalkylchitosan | |
DK3642136T3 (da) | Veksellad | |
DK3395159T3 (da) | Ballepresse | |
ES1205411Y (es) | Maleta-Gaveta | |
ES1198359Y (es) | Columbario | |
FI11529U1 (fi) | Ontelolaatan kannake | |
DK3645955T3 (da) | Buffertank |